21 min
Episode 38: Beyond the High-Medical Cannabis & It's Impact on Women's Health with Dr. Staci Gruber, PART 2 Taboo to Truth: Unapologetic Conversations About Sexuality in Midlife
-
- Sexuality
In part 2 of my interview with Dr Staci Gruber, we delved into the complexities of cannabis use, including its potential for addiction, known formally as Cannabis Use Disorder (CUD). We also touched upon the evolution of cannabis potency over the years, with today's products containing much higher THC levels than those from decades ago, raising the stakes in the risk-benefit analysis of cannabis consumption. The conversation further explored the medical applications of cannabis, highlighting its utility in managing pain, sleep disorders, and other health issues. The conversation also ventured into the areas of women's health, underscoring the lack of research and the growing interest in cannabis for managing conditions like endometriosis and menopause symptoms. It was a reminder of the importance of being an informed consumer, understanding the goal of your cannabis use, and ensuring the safety and efficacy of the products you choose. Our dialogue underscored the evolving landscape of cannabis use and research, highlighting the need for more education and open conversations between consumers and healthcare providers to navigate the complexities of cannabis as both a medicinal and recreational substance. Watch the full episode here. About Dr. Gruber Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber’s research focuses on the application of neurocognitive models and brain imaging to characterize risk factors for substance abuse and psychiatric conditions. Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery (MIND) in 2014, the first-ever program of its kind designed to clarify the long-term impact of medical cannabis use. Dr. Gruber also launched the Women’s Health Initiative at MIND, or WHIM, the first cannabis-focused program designed specifically to address women’s health and disorders that disproportionately affect women as well as some transgender and non-binary individuals. ********************************************************** Have a burning question or topic suggestion? karen@taboototruth.com https://www.taboototruth.com/ https://www.instagram.com/taboototruth https://www.youtube.com/@taboototruthpodcast *this podcast is not intended to give medical advice. Karen Bigman is not a medical professional. For any medical questions or issues, please visit your medical provider.
--- Send in a voice message: https://podcasters.spotify.com/pod/show/taboototruth/message
Become a supporter of this podcast: https://www.spreaker.com/podcast/taboo-to-truth-unapologetic-conversations-about-sexuality-in-midlife--6179447/support.
In part 2 of my interview with Dr Staci Gruber, we delved into the complexities of cannabis use, including its potential for addiction, known formally as Cannabis Use Disorder (CUD). We also touched upon the evolution of cannabis potency over the years, with today's products containing much higher THC levels than those from decades ago, raising the stakes in the risk-benefit analysis of cannabis consumption. The conversation further explored the medical applications of cannabis, highlighting its utility in managing pain, sleep disorders, and other health issues. The conversation also ventured into the areas of women's health, underscoring the lack of research and the growing interest in cannabis for managing conditions like endometriosis and menopause symptoms. It was a reminder of the importance of being an informed consumer, understanding the goal of your cannabis use, and ensuring the safety and efficacy of the products you choose. Our dialogue underscored the evolving landscape of cannabis use and research, highlighting the need for more education and open conversations between consumers and healthcare providers to navigate the complexities of cannabis as both a medicinal and recreational substance. Watch the full episode here. About Dr. Gruber Dr. Staci Gruber is the Director of the Cognitive and Clinical Neuroimaging Core at McLean Hospital’s Brain Imaging Center and an Associate Professor of Psychiatry at Harvard Medical School. Dr. Gruber’s research focuses on the application of neurocognitive models and brain imaging to characterize risk factors for substance abuse and psychiatric conditions. Dr. Gruber launched Marijuana Investigations for Neuroscientific Discovery (MIND) in 2014, the first-ever program of its kind designed to clarify the long-term impact of medical cannabis use. Dr. Gruber also launched the Women’s Health Initiative at MIND, or WHIM, the first cannabis-focused program designed specifically to address women’s health and disorders that disproportionately affect women as well as some transgender and non-binary individuals. ********************************************************** Have a burning question or topic suggestion? karen@taboototruth.com https://www.taboototruth.com/ https://www.instagram.com/taboototruth https://www.youtube.com/@taboototruthpodcast *this podcast is not intended to give medical advice. Karen Bigman is not a medical professional. For any medical questions or issues, please visit your medical provider.
--- Send in a voice message: https://podcasters.spotify.com/pod/show/taboototruth/message
Become a supporter of this podcast: https://www.spreaker.com/podcast/taboo-to-truth-unapologetic-conversations-about-sexuality-in-midlife--6179447/support.
21 min